Clinical Trial

Enhancing Smoking Cessation for African American People Everywhere

Study acronym: ESCAPE
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participants will be randomized into one of three conditions: (1) the intervention, ESCAPE (Enhancing Smoking Cessation for African American People Everywhere) + Nicotine Replacement Medications (NRT), (2) the National Cancer Institute's (NCI) quitSTART app, the standard mobile smoking cessation treatment + NRT, and (3) an assessment-only control group + NRT.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-14
notable Primary completion pushed: 2029-05-30 -> 2029-06-30 2026-05-21
minor Completion pushed: 2029-05-30 -> 2029-06-30 2026-05-21
Trial Details
NCT Number NCT07024992
Lead Sponsor University of Houston
Collaborators: University of Oklahoma
Conditions ESCAPE Intervention+NRT, quitSTART Intervention+NRT, CTRL+NRT
Enrollment 300 participants
Start Date 2026-06-30
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13